Roberts S. Negrin
#128,764
Most Influential Person Now
Roberts S. Negrin's AcademicInfluence.com Rankings
Roberts S. Negrinphilosophy Degrees
Philosophy
#6158
World Rank
#9148
Historical Rank
Logic
#3345
World Rank
#4490
Historical Rank

Roberts S. Negrinbiology Degrees
Biology
#8333
World Rank
#11395
Historical Rank
Immunology
#472
World Rank
#489
Historical Rank

Download Badge
Philosophy Biology
Roberts S. Negrin's Degrees
- Doctorate Medicine Stanford University
- PhD Immunology Stanford University
Why Is Roberts S. Negrin Influential?
(Suggest an Edit or Addition)Roberts S. Negrin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation (2003) (1236)
- Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. (1999) (951)
- Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. (2001) (947)
- Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity (1991) (569)
- Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. (2006) (488)
- A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. (1994) (457)
- Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. (2005) (441)
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey (2015) (423)
- Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. (2008) (387)
- Thomas' hematopoietic cell transplantation (2003) (379)
- Visualizing the kinetics of tumor-cell clearance in living animals. (1999) (374)
- Use of reporter genes for optical measurements of neoplastic disease in vivo. (2000) (373)
- Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. (2004) (365)
- In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. (2005) (365)
- Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. (2005) (359)
- Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. (1996) (355)
- Shifting foci of hematopoiesis during reconstitution from single stem cells (2003) (352)
- American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. (1999) (344)
- Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. (2003) (336)
- Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. (1993) (330)
- Protective conditioning for acute graft-versus-host disease. (2005) (323)
- High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. (1997) (320)
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. (2010) (296)
- Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model (1997) (296)
- Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. (1993) (285)
- Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. (2014) (276)
- Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. (1993) (271)
- Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. (2003) (268)
- Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy (2006) (263)
- Noninvasive assessment of tumor cell proliferation in animal models. (1999) (253)
- Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation (2009) (251)
- Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells (2009) (236)
- Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. (2001) (234)
- Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. (1990) (231)
- In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. (2007) (225)
- Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial. (1989) (222)
- Advancing animal models of neoplasia through in vivo bioluminescence imaging. (2002) (216)
- Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. (1995) (215)
- A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. (2005) (215)
- Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. (1996) (207)
- Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. (2004) (203)
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (187)
- Thalidomide as salvage therapy for chronic graft-versus-host disease. (1995) (180)
- Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. (2011) (179)
- In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease (2006) (175)
- The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. (2008) (174)
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. (2008) (169)
- Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. (2000) (167)
- TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. (2009) (162)
- Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. (1993) (158)
- High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. (2001) (156)
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. (2011) (148)
- Bioluminescence imaging of lymphocyte trafficking in vivo. (2001) (145)
- Transplanted Terminally Differentiated Induced Pluripotent Stem Cells Are Accepted By Immune Mechanisms Similar To Self-Tolerance (2014) (142)
- Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. (2012) (138)
- CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial (2021) (135)
- A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. (1998) (132)
- Activated T cells and cytokine-induced CD3+CD56+ killer cells (1997) (132)
- Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. (2011) (130)
- Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. (1998) (129)
- Propagation of large numbers of T cells with natural killer cell markers (1994) (128)
- Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. (1995) (128)
- Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells1 (2005) (128)
- The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia. (2007) (126)
- Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. (2005) (123)
- Dynamic assessment of quality of life after autologous bone marrow transplantation. (1992) (122)
- Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. (2008) (120)
- Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation (2017) (113)
- Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study (2006) (113)
- Mouse models of bone marrow transplantation. (2008) (108)
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. (2012) (107)
- Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. (2011) (106)
- Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. (2008) (103)
- Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. (2005) (100)
- Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience. (2008) (98)
- Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma. (2001) (97)
- Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. (1996) (95)
- Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. (1995) (95)
- Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation. (2001) (93)
- Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. (2007) (91)
- High-Dose N-Acetylcysteine in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (2005) (91)
- Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. (1994) (90)
- Evaluation of effector cell fate and function by in vivo bioluminescence imaging. (2003) (88)
- Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. (2006) (87)
- Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. (1996) (87)
- Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma. (2010) (84)
- CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells. (2014) (83)
- Impact of Mammalian Target of Rapamycin Inhibition on Lymphoid Homing and Tolerogenic Function of Nanoparticle-Labeled Dendritic Cells following Allogeneic Hematopoietic Cell Transplantation1 (2008) (83)
- Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T‐regulatory cells (2009) (82)
- Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation. (2013) (82)
- Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. (1997) (81)
- A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. (2017) (80)
- Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. (2009) (79)
- Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. (1993) (77)
- Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging. (1991) (76)
- Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. (1993) (75)
- Graft-versus-host disease versus graft-versus-leukemia. (2015) (75)
- TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. (2016) (75)
- Understanding immune cell trafficking patterns via in vivo bioluminescence imaging (2002) (74)
- A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. (2000) (73)
- Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. (2011) (73)
- High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience. (2001) (72)
- Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis (2000) (71)
- Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation (2014) (70)
- Studies of ex Vivo Activated and Expanded CD8+ NK-T Cells in Humans and Mice (2002) (69)
- Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. (1994) (68)
- Interleukin-2 receptor downstream events in regulatory T cells: Implications for the choice of immunosuppressive drug therapy (2008) (68)
- Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. (2004) (67)
- Energy-transducing H+-ATPase of Escherichia coli. Reconstitution of proton translocation activity of the intrinsic membrane sector. (1980) (67)
- Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. (1999) (67)
- Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. (2000) (66)
- Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality. (2015) (66)
- Role of naturally arising regulatory T cells in hematopoietic cell transplantation. (2006) (65)
- Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. (2000) (65)
- A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease. (2013) (64)
- Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. (2005) (60)
- Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors. (1997) (59)
- Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. (2005) (59)
- T cells expressing chimeric antigen receptor promote immune tolerance. (2017) (58)
- Foxp3+ regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis (2017) (57)
- Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia. (1995) (56)
- Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells. (2017) (56)
- Nasal continuous positive airway pressure in atelectasis. (1987) (56)
- Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. (1996) (54)
- Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. (2012) (54)
- MLL leukemia induction by genome editing of human CD34+ hematopoietic cells. (2015) (54)
- CD2-mediated IL-12–dependent signals render human γδ-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies (2000) (54)
- Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization (2016) (52)
- Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays. (2014) (52)
- CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. (2011) (52)
- High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. (2000) (51)
- Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells. (2013) (51)
- Cellular immunotherapy and autologous transplantation for hematologic malignancy (1997) (51)
- CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells (2001) (51)
- CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells. (2010) (50)
- Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma. (2021) (50)
- Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation1 (2009) (50)
- The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data. (1991) (49)
- CD31 mismatching affects marrow transplantation outcome. (2001) (49)
- Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3. (2002) (49)
- Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes (2015) (48)
- Biology and clinical effects of natural killer cells in allogeneic transplantation (2010) (48)
- A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. (1994) (48)
- Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway. (2019) (48)
- Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. (1997) (47)
- Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells. (2017) (47)
- Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. (1994) (46)
- Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes. (1990) (46)
- Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. (1994) (46)
- Effects of CSFs in preleukemia. (1990) (45)
- Thomas' hematopoietic cell transplantation : stem cell transplantation (2015) (45)
- Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. (2000) (45)
- Regulation of different inflammatory diseases by impacting the mevalonate pathway (2009) (45)
- CD101 Surface Expression Discriminates Potency Among Murine FoxP3+ Regulatory T Cells1 (2007) (44)
- Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease. (2015) (44)
- Role of NKG 2 D signaling in the cytotoxicity of activated and expanded CD 8 T cells (2004) (43)
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. (2007) (42)
- Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease (2015) (42)
- Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy (2015) (42)
- CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies. (2000) (41)
- CD22-Directed CAR T-Cell Therapy Induces Complete Remissions in CD19-Directed CAR-Refractory Large B-Cell Lymphoma. (2020) (40)
- Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF. (1990) (39)
- Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation (2017) (39)
- Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. (2005) (39)
- CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies. (2005) (37)
- Analysis of human hematopoietic stem cell populations. (1994) (36)
- Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. (2001) (36)
- ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. (2011) (35)
- Mapping immune processes in intact tissues at cellular resolution. (2012) (35)
- Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells. (2012) (34)
- DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease. (2016) (34)
- Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells (2005) (34)
- Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET (2020) (33)
- Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients. (2019) (32)
- MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors. (2020) (32)
- The use of the polymerase chain reaction for the detection of minimal residual malignant disease. (1991) (31)
- Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. (2009) (31)
- Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cells. (2010) (29)
- Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. (2014) (29)
- Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation. (2012) (28)
- CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. (2007) (28)
- Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cells. (1994) (28)
- Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation. (2018) (26)
- Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase (1994) (26)
- Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. (1999) (26)
- Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease (2015) (25)
- Hodgkin disease‐derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis (2001) (24)
- Ferrichrome transport in inner membrane vesicles of Escherichia coli K12. (1978) (24)
- Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion (2020) (24)
- Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance. (2021) (24)
- Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. (1990) (23)
- Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. (1994) (23)
- G-CSF and peripheral blood progenitor cells (1992) (23)
- Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells. (2013) (22)
- Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. (2014) (22)
- Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution (2018) (22)
- Sirolimus and Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation (2008) (22)
- H+-ATPase of Escherichia coli uncB402 mutation leads to loss of chi subunit of subunit of F0 sector. (1983) (21)
- The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow. (1993) (21)
- Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms. (2014) (20)
- Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation. (1995) (20)
- NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment (2016) (19)
- Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease (2015) (19)
- Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion (2014) (19)
- A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model (2013) (18)
- Lymphokine-activated killer cell activity after cryopreservation. (1989) (17)
- Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma. (2010) (17)
- Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission (1993) (17)
- TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment (2016) (17)
- High dose etoposide‐based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma (1996) (17)
- Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy (2021) (16)
- Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies (1995) (16)
- Autografting in chronic myelogenous leukemia: new questions. (1995) (16)
- Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia. (2021) (16)
- A killer choice for cancer immunotherapy (2014) (16)
- Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. (2000) (16)
- Cancer vaccines and T cell therapy. (2013) (16)
- Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. (2020) (16)
- Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. (1994) (15)
- Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo1 (2008) (15)
- A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma (1995) (15)
- Methods for imaging cell fates in hematopoiesis. (2007) (15)
- Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation. (2006) (14)
- Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease. (2007) (14)
- Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial (2020) (13)
- In vitro and in vivo activity of murine lymphokine‐activated killer cells after cryopreservation (1992) (13)
- Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity (2012) (13)
- High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. (2006) (13)
- The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes. (1990) (13)
- Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease (2019) (13)
- Use and Toxicity of the Colony-Stimulating Factors (1993) (13)
- Regulatory T Cell Immunotherapy in Immune-Mediated Diseases (2015) (12)
- Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease (2020) (12)
- Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms. (2019) (12)
- 128Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation (2003) (12)
- Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation. (2011) (11)
- Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma (2012) (11)
- Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy. (2000) (11)
- Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming (2021) (11)
- The role of N-linked carbohydrate residues in lymphokine-activated killer cell-mediated cytolysis. (1994) (11)
- A novel technique for the enrichment of primary ovarian cancer cells. (2007) (10)
- Introduction to a review series on chronic GVHD: from pathogenic B-cell receptor signaling to novel therapeutic targets. (2017) (10)
- Autologous hematopoietic cell transplantation for high-risk ALL (2011) (10)
- Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation. (2017) (10)
- Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib (2016) (10)
- Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with follicular non-hodgkins lymphoma (FL) beyond first complete response or first partial response (2008) (9)
- Role of regulatory T cell populations in controlling graft vs host disease. (2011) (9)
- Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results in Low Chronic Gvhd (2008) (9)
- Is Nitrous Oxide Safe for Bone Marrow Harvest? (1995) (9)
- Engraftment of chronic myeloid leukemia in SCID mice (1998) (9)
- Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY (2011) (9)
- Rapid engraftment after allogeneic transplantation of density‐enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies (2001) (9)
- Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4+CD25+Foxp3+ Regulatory T Cells. (2009) (9)
- Type II HMG-CoA Reductase Inhibitors (Statins) Provide Acute-Graft-Versus-Host Disease Protection by Th-2 Cytokine Induction While Sparing Graft-Versus-Leukemia Activity. (2006) (9)
- Cytokine Induced Killer (CIK) Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation. (2006) (9)
- Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort. (2019) (8)
- Introduction to the review series on "Advances in hematopoietic cell transplantation". (2014) (8)
- Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using total lymphoid irradiation and anti-thymocyte globulin conditioning (2015) (8)
- Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report (2019) (8)
- A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease (2016) (8)
- High-Parametric Evaluation of Human Invariant Natural Killer T Cells to Delineate Heterogeneity in Allo- and Autoimmunity. (2020) (8)
- Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence. (2002) (8)
- HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity. (2017) (8)
- Comprar Thomas' Hematopoietic Cell Transplantation, 4th Edition | Karl G. Blume | 9781405153485 | Wiley (2009) (8)
- What We Have Learned and What We Need to Know (2006) (7)
- Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma (2018) (7)
- Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes. (1995) (7)
- Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report (2022) (7)
- Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (7)
- Early CD 30 signaling is critical for adoptively transferred CD 4 CD 25 regulatory T cells in prevention of acute graft-versus-host disease (2007) (7)
- Immune regulation in hematopoietic cell transplantation (2019) (7)
- Engraftment of embryonic stem cells and differentiated progeny by host conditioning with total lymphoid irradiation and regulatory T cells. (2015) (7)
- Promise and Challenges of Human Regulatory T Cells in the Clinic (2007) (6)
- Long Term Results of Autologous Hematopoietic Cell Transplantation (AHCT) for Peripheral T Cell Lymphoma: The Stanford Experience. (2007) (6)
- A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells. (2020) (6)
- Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model (2010) (6)
- Use of the polymerase chain reaction for the detection of tumor cell involvement of bone marrow and peripheral blood: implications for purging. (1992) (6)
- European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation (2014) (6)
- Bone marrow transplantation for hematologic malignancies: the Stanford experience. (1990) (6)
- Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents. (2020) (6)
- IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation. (2013) (6)
- Assays to determine hematopoietic stem cell content in blood or marrow grafts. (1999) (6)
- Treatment with agonistic DR 3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease (2015) (5)
- Inhibition of Protein Geranylgeranylation and Farnesylation Protects Against GVHD (2011) (5)
- A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer. (1999) (5)
- Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma (2020) (5)
- Immunotransplant for mantle cell lymphoma: Phase I/II study preliminary results. (2011) (5)
- Invariant natural killer T-cell subsets have diverse graft-versus-host-disease – preventing and antitumor effects (2021) (5)
- Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility (2013) (5)
- Prevention of acute graft-versus-host disease despite compensatory function of lymphoid organs in vivo (2006) (5)
- Prediction of response to G-CSF and epo treatment for the anaemia of myelodysplastic syndromes (MDS) (1994) (5)
- Cellular immunotherapy following autologous hematopoietic progenitor cell transplantation. (1997) (5)
- Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation. (2007) (4)
- Immunoglobulin G Fc Polymorphism Is Correlated with Rituximab-Induced Neutropenia Following Autologous Hematopoietic Cell Transplantation. (2004) (4)
- Invariant Natural Killer T Cell Subsets Have Diverse Graft-Versus-Host-Disease-Preventing and Anti-Tumor Effects. (2021) (4)
- Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients (2015) (4)
- Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant. (2020) (4)
- calcineurin-dependent interleukin-2 production Inhibition of CD4+CD25+ regulatory T-cell function by (2013) (4)
- Prevention of Acute Graft-Versus-Host Disease Despite Compensatory Function of Lymphoid Organs In Vivo. (2005) (4)
- Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma. (2016) (4)
- Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma (2021) (4)
- Deep B and T Cell Repertoire Sequencing to Evaluate Minimal Residual Disease and T Cell Responses in a Therapeutic Vaccine Trial for Mantle Cell Lymphoma (2012) (4)
- Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD. (2021) (4)
- Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients. (2021) (3)
- NKT Cells Are Potent Regulators of GVHD Following Adoptive Transfer in Allogeneic BMT. (2007) (3)
- Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Host Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin Confirm a Low Incidence of Graft Versus Host Disease (GVHD) and Retained Graft Anti-Tumor Activity. (2006) (3)
- Safety Of Nitrous Oxide For Bone Marrow Harvests (1992) (3)
- Autologous Cytokine-Induced Killer Cells as Post-Transplant Cellular Immunotherapy. (2007) (3)
- Rituximab Infusion Two Months after Nonmyeloablative Transplantation Maintains B-Cell Disease Control with Minimal GVHD. (2006) (3)
- Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation. (1996) (3)
- Transplantation of Peripheral Blood Cells As Compared with Bone Marrow From HLA-Identical Related Donors Is Associated with Superior Long-Term Outcomes (2011) (3)
- Orca-T, a Precision Treg-Engineered Donor Product, Prevents Acute Gvhd with Less Immunosuppression in an Early Multicenter Experience with Myeloablative HLA-Matched Transplants (2020) (3)
- Differential impact of mTOR inhibition on CD4CD25Foxp3 regulatory T cells as compared to conventional CD4 T cells Running title: Impact of mTOR inhibition on Treg and Tconv (2007) (3)
- Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies (2022) (3)
- Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning (2016) (3)
- 283: Rituximab infusion two months after total lymphoid irradiation-antithymocyte globulin (TLI-ATG) nonmyeloablative transplantation maintains B-cell disease control with minimal GVHD (2007) (3)
- A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells. (2013) (3)
- CD22-CAR T-Cell Therapy Mediates High Durable Remission Rates in Adults with Large B-Cell Lymphoma Who Have Relapsed after CD19-CAR T-Cell Therapy (2021) (3)
- In Vivo Imaging of GVHD and GVL (2019) (3)
- A phase I trial with extended cohort of gemcitabine and vinorelbine followed by autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin’s lymphoma (2005) (3)
- CD22-Directed CAR T-Cell Therapy Mediates Durable Complete Responses in Adults with Relapsed or Refractory Large B-Cell Lymphoma after Failure of CD19-Directed CAR T-Cell Therapy and High Response Rates in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (2020) (3)
- Haploidentical Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Conditioning Protects Against Acute Graft Versus Host Disease (GVHD). (2005) (3)
- Management of Relapse after Hematopoietic Cell Transplantation (2009) (3)
- NK Cells Suppress Gvhd by Directly Inhibiting Activated Alloreactive T Cells through An NKG2D-Mediated Mechanism (2008) (2)
- Cells and Hematopoietic Progenitor Cells ( CD 34 " ) in the Blood of Normal Donors (1997) (2)
- Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. (2005) (2)
- IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells (2017) (2)
- Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms (2015) (2)
- Prevention of Acute Graft-Versus-Host Disease by CD4+CD25+ Regulatory T Cells Is Dependent on the CD30/CD153 Pathway. (2005) (2)
- Granulocyte colony stimulating factor plus erythropoietin for the maintenance treatment of the anemia of myelodysplastic syndromes (1994) (2)
- Precision-Engineered Cell Therapy Orca-T Demonstrates High Relapse-Free Survival at 1 Year While Reducing Graft-Versus-Host Disease and Toxicity (2022) (2)
- Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo. (2022) (2)
- Bleeding and Thrombosis Are Associated with Endothelial Dysfunction in CAR-T Cell Therapy and Are Increased in Patients Experiencing Neurologic Toxicity (2020) (2)
- CD4+CD25+ Regulatory T Cells Enhance Immune Reconstitution Following Allogeneic Hematopoietic Cell Transplantation by Protecting Thymic and Lymphoid Compartments from Graft-Versus-Host Disease Damage without Impacting T Cell Repertoire Development. (2006) (2)
- Immune regulatory networks in the post-transplant setting. (2008) (2)
- In vivo imaging of graft-versus-host disease and graft-versus-leukemia (2013) (2)
- Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor vs. G-CSF +/- Plerixafor in the Lenalidomide Era. (2021) (2)
- CD4+ Invariant Natural Killer T Cells Protect from Acute Graft-Versus-Host Disease Lethality through a Dramatic Expansion of Donor-Derived CD4+FoxP3+ Regulatory T Cells (2014) (2)
- Functional Comparison of Freshly Isolated and Ex-Vivo Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Suppressing Murine Acute GvHD (2008) (2)
- Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. (1990) (2)
- Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure (2010) (2)
- Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy (2015) (2)
- Allogeneic Bone Marrow Transplantation for BCR-ABL Positive Acute Lymphoblastic Leukemia (2001) (2)
- Emerging Therapies for Chronic GVHD (2002) (2)
- Engineered IL-2 Cytokine-Cytokine Receptor Complex Enables Selective Expansion of Regulatory T Cells and Facilitates Establishment of Organ Transplantation Tolerance (2020) (2)
- Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis (2015) (2)
- Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD. (2022) (2)
- Minimal residual disease (1998) (2)
- Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS) (2014) (2)
- Therapy of hematopoietic disorders with recombinant colony-stimulating factors. (1992) (2)
- Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (2021) (2)
- Monitoring Measurable Residual Disease Using Peripheral Blood in Acute Lymphoblastic Leukemia: Results of a Prospective, Observational Study (2020) (2)
- Mesenchymal Stem Cells (MSC) Are Not Intrinsically Immune Privileged: Direct Demonstration in TCR Transgenic Mice and by Imaging of Allogeneic Luciferase+ MSC in Immune Competent Vs Immune Deficient Mice (2008) (1)
- Engraftment and Survival Following Non-Myeloablative Allogeneic Peripheral Blood Hematopoietic Cell Transplantation for Malignant Diseases Is Affected by CD8 + T-Cell Dose. (2004) (1)
- Distinct Immune Regulatory Potential of Invariant Natural Killer T (iNKT) Cell Subsets: iNKT2 and iNKT17, but Not iNKT1, Protect from Graft-Versus-Host-Disease (2019) (1)
- Impact of mTOR Inhibition on FoxP3+ Regulatory T Cells as Compared to Conventional T Cells after Allogeneic Bone Marrow Transplantation. (2006) (1)
- Multi-modality Imaging Identifies Key Times for Annexin V Imaging as an Early Predictor of Therapeutic Outcome (2004) (1)
- Donor Requirements For CD4+CD25+FoxP3+ Regulatory T Cells Capable Of Suppressing CD4+ and CD8+ Conventional T Cell Proliferation and Graft Versus Host Disease (2013) (1)
- Immunotherapy of Primary Ovarian Cancer Using Autologous Cytokine Induced Killer Cells Retargeted with Bispecific Antibodies: A Preclinical Study. (2005) (1)
- Loss of CD62L Expression in CD4+FoxP3+ Regulatory T Cells Following Freeze-and-Thaw Prevents Protection Against GVHD in Murine Models (2014) (1)
- Consolidative CD8+ Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation (2017) (1)
- TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment (2015) (1)
- PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA (2017) (1)
- Ewing's sarcoma/PNET tumor cell lines express Her2/neu which can be utilized as a target by redirected T cells (2000) (1)
- Welcome to Blood Advances. (2016) (1)
- Allogeneic hematopoietic cell transplant for normal karyotype acute myeloid leukemia: Indirect evidence of selection for adverse molecular profile (2015) (1)
- The use of colony stimulating factors in clinical bone marrow transplantation. (1992) (1)
- Third Party Invariant Natural Killer T Cells Protect from Graft-Versus-Host Disease Lethality through Expansion of Donor CD4 + FoxP3 + Regulatory T Cells (2014) (1)
- Non-Myeloablative Conditioning of Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Protects Against Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (HCT) but Retains Anti-Tumor Activity. (2004) (1)
- Enhanced immune reconstitution and function by CD4+CD25+ regulatory T cells following allogeneic hematopoietic cell transplantation (2006) (1)
- Long-Term Outcomes of Myeloablative Conditioning and Matched-Related Donor Hematopoietic Cell Transplantation for Patients with High-Risk and Advanced-Stage Hematolymphoid Malignancies (2008) (1)
- S237: ORCA-T, AN ENGINEERED ALLOGRAFT, RESULTS IN HIGH GVHD-FREE AND RELAPSE-FREE SURVIVAL FOLLOWING MYELOABLATIVE CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES (2022) (1)
- Imaging alloreactive T cells provides early warning of organ transplant rejection (2021) (1)
- SECTION X: REGULATORY T CELLS Natural and Expanded CD4 1 CD25 1 Regulatory T Cells in Bone Marrow Transplantation (2011) (1)
- Inflammatory TH1 Cytokines in Target Tissues Promote the Recruitment of Alloreactive T Cells in Graft-Versus-Host Disease. (2009) (1)
- Only the CD62L (cid:1) subpopulation of CD4 (cid:1) CD25 (cid:1) regulatory T cells protects from lethal acute GVHD (2005) (1)
- protects from lethal acute GVHD Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells (2013) (1)
- In Vivo Effects of Cyclosporine A, Mycophenolate Mofetile and Rapamycin on Adoptively Transferred CD4+CD25+ Regulatory T Cells in Prevention of Experimental Acute Graft-Versus-Host Disease. (2005) (1)
- Three-Dimensional Visualization of Immunological Processes of Entire Organs in Subcellular Resolution. (2009) (1)
- Selective Expansion of Human Regulatory (CD4+CD25+CD127LowFOXP3+) Cells to High Purity by Inhibiting Expansion of CD4+CD25+CD127HighFOXP3-Conventional T Cells with Rapamycin. (2006) (1)
- Natural Killer Cell Adoptive Immunotherapy Is Hampered by A Rapid Development of NK Cell Dysfunction Characterized by Loss of Effector Mechanisms and Downregulation of the Transcription Factors T-Bet and Eomesodermin; Definition and Possible Mechanism of NK Cell Exhaustion (2011) (1)
- Depletion of Host Dendritic Cells During the Effector Phase of GVHD Enhances Acute GVHD and Mortality (2012) (1)
- Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents (2019) (1)
- Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results (2011) (1)
- Dose-Intense BCNU/Melphalan Regimen Followed By Autologous Hematopoietic Cell Transplantation (AHCT) Results in Prolonged PFS in Myeloma Patients (2019) (1)
- Total lymphoid irradiation and transplantation tolerance (2006) (1)
- Immunotransplant Expands Vaccine-Induced Memory T Cell Responses In Patients With Mantle Cell Lymphoma (2013) (1)
- Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation (2016) (1)
- Silencing human NKG2D, DAP10 and DAP12 reduces cytotoxicity of in vivo activated CD8+ T and NK cells (2005) (1)
- Early Treatment with CD4+CD25+ Regulatory T Cells Provides Prolonged Suppressive Effects Which Control Evolving but Not Established Graft-Versus-Host-Disease. (2005) (1)
- In Vivo Trafficking of CD4+CD25+ Regulatory T-Cells in Allogeneic Recipients Using Bioluminescence Imaging. (2004) (1)
- The Expansion of Gastrointestinal-associated αβ T Cell Clones in Peripheral Blood Over Time Is a Disease Feature of Severe Acute Graft-Versus-Host Disease (2012) (1)
- following allogeneic hematopoietic cell transplantation Regulatory T cells and natural killer T cells for modulation of GVHD (2013) (1)
- Impact of proteasome inhibitor vs. IMiD maintenance therapy on outcomes of patients with high-risk multiple myeloma (HRMM). (2020) (1)
- CD 4 1 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD 4 1 CD 25 1 FoxP 3 1 regulatory T cells (2014) (1)
- TRANSPLANTATION Mast cells suppress murine GVHD in a mechanism independent of CD4 1 CD25 1 regulatory T cells (2013) (0)
- Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide Mobilization Vs. G-CSF ± Plerixafor Mobilization in the Lenalidomide Era (2021) (0)
- Transcriptome Identifies Mechanisms of 1 Regulatory T cell ( Treg ) Suppression of Acute Graft-versus-Host-Disease 2 3 (2022) (0)
- cells T + regulatory T cells compared with conventional CD4 + Foxp3 + CD25 + Differential impact of mammalian target of rapamycin inhibition on CD4 (2008) (0)
- CD62L and CD31 Matching Are Independent Risk Factors for Survival after Bone Marrow Transplantation. (2005) (0)
- Invariant Natural Killer T Cell Subsets Have Diverse Functions: iNKT2 and iNKT17 Protect from Graft-Versus-Host-Disease, Whereas iNKT1 Have Antitumor Potential (2018) (0)
- Bone marrow-derived mesenchymal stem cells are recruited to the brain but do not differentiate into neuronalphenotypes in mouse models of stroke (2010) (0)
- Increased Activity in the T Cell Effector Phase and Enhanced T Cell Repertoire Target-Tissue Stability Distinguish Alloreactivity Across Major Versus Minor Histocompatibility Barriers (2015) (0)
- Utilization of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation (0)
- T Cell Trafficking in Acute GVHD: In Vivo Bioluminescence Evaluation To Elucidate the Role of Different Lymphatic Organs. (2004) (0)
- Analysis of Bendamustine Lymphodepletion, CD19 CART Expansion, Safety and Efficacy in Patients with Rel/Ref Non-Hodgkin Lymphoma (2022) (0)
- Isolation of Both Normal and Leukemic Cells Within the Hematopoietic Stem Cell Compartment of Chronic Myelogenous Leukemia Mobilized Peripheral Blood (2020) (0)
- Comparison of four categorized risk scoring systems for analyzing outcome in advanced MDS (1994) (0)
- Compositions and methods for the protection of organs, tissues and cells from damage mediated by the immune system (1999) (0)
- Tissue Damage and Lymphoma Derived Chemoattractive Signals Impact Regulatory T Cell Trafficking After Allogeneic Hematopoietic Cell Transplantation. (2009) (0)
- NK Cells Induce Alloreactive Donor T Cell Apoptosis and Decrease Proliferation in GVHD Induction. (2007) (0)
- Development of a minimally invasive bone marrow harvest device and method for the rapid extraction of bone marrow for use in bone marrow transplantation and stem cell therapy (2005) (0)
- Inhibitory Effects of Cytotoxicity of Cytokine Activated and Expanded Human CD8+ T Cells by a Human NKG2D Alternative Splice Variant. (2004) (0)
- Murine CIK cells show tumor specific cytolysis in CD107a based degranulation analysis (2005) (0)
- Use of R-spondin1, An Intestinotrophic Mitogen, in the Treatment of Murine Graft-Versus-Host Disease (2008) (0)
- Anti-CD22 CAR T-Cell Therapy Mediates Durable Complete Responses in Adults with Relapsed or Refractory Large B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy and High Response Rates in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (2021) (0)
- Equivalence of 2 Effective Graft-Versus-Host Disease Prophylaxis Regimens : Results of a Pro s p e c t i ve (2000) (0)
- The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models (2016) (0)
- In vivo trafficking and proliferation of natural killer cells in murine models of bone marrow transplantation (2006) (0)
- Infusion of Syngeneic Apoptotic Cells Prior to Bone Marrow Transplantation Decreases Tcell Proliferation and Increases Survival (2012) (0)
- Assessment of Tumor Depletion Following Tandem Mobilization in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (2014) (0)
- Host CD4+CD25+FoxP3+ Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation (2013) (0)
- using in vivo bioluminescence imaging Revealing lymphoma growth and the efficacy of immune cell therapies (2013) (0)
- 39: Differential impact of mTOR inhibition on FoxP3+ regulatory T cells as compared to conventional T cells after allogeneic bone marrow transplantation (2007) (0)
- Long-term outcomes of high-dose therapy using busulfan, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for patients with high-risk or advanced stages of myeloid malignancies. (2009) (0)
- CT-524 Orca-T, A Precision Engineered Allograft, Results in High GVHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies. (2022) (0)
- A Novel Antibody-Cell Conjugation Method to Enhance Cellular Therapies for the Treatment of Hematological Malignancies (2017) (0)
- Allogeneic Environment and Tissue Damage Provide Critical Stimuli for Regulatory T Cell Expansion and Survival In Vivo after Hematopoietic Cell Transplantation. (2006) (0)
- Housing Deadline for Tandem BMT Meetings (2002) (0)
- NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P.233) (2015) (0)
- A killer choice for cancer immunotherapy (2014) (0)
- Orca-T, a High-Precision Cell Therapy, for the Treatment of Hematologic Malignancies in Patients with 7/8 Mismatch Donors (2023) (0)
- The Expansion of Gastrointestinal-Associated αβ T Cell Clones in Peripheral Blood Associates with Severe Steroid Refractory GVHD (2013) (0)
- Analytical Validity of Deep Sequencing to Characterize Tissue-Infiltrating Lymphocytes (2012) (0)
- Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant (2020) (0)
- F.122. Deletion in H-NKG2D Ligand Effects Tumors Resistance to T-Cells Mediated Cytotoxicity (2006) (0)
- Erratum (2005) (0)
- the Stanford University Results and Prognostic Indices of Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis High-Dose Therapy and Autologous Hematopoietic Progenitor Cell (2013) (0)
- The Use of Granulocyte Colony Stimulating Factor for the Treatment of Patients with Myelodysplastic Syndromes (1992) (0)
- allogeneic transplantation effective strategies to control graft-versus-host disease following In vivo dynamics of regulatory T-cell trafficking and survival predict (2013) (0)
- third-party central memory CD8 T cells - nonreactive anti A new approach for eradication of residual lymphoma cells by host (2013) (0)
- Recruitment and Differentiation of Endogenous Bone Marrow.Derived Mesenchymal Stem Cells after cerebral Ischemia (2012) (0)
- MAb therapy comes of age (2000) (0)
- Stem Cell Transplantation Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic (2013) (0)
- Recipient-speci fi c T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant (2020) (0)
- Karl Georg Blume, MD (2013) (0)
- Multi-parameter optical imaging of immune cell activity in chimeric antigen receptor T-cell and checkpoint blockade therapies (2021) (0)
- Foxp3+ regulatory T Cells Maintain Bone Marrow Microenvironment for B Cell Differentiation from Hematopoietic Stem Cells (2016) (0)
- Differential effects of immunosuppressants on adoptively transferred CD4+CD25High regulatory T cells in prevention of experimental acute graft-versus-host disease (2006) (0)
- Trafficking and Expansion of NK Cells in Murine Models of Bone Marrow Transplantation. (2005) (0)
- Impact of Conditioning Regimen and Donor Type on Outcomes of Allogeneic Stem Cell Transplant for Myelofibrosis – a Single Institutional Experience (2021) (0)
- Adoptive Transfer Of Ex Vivo “Educated” CD4+CD25+FoxP3+ Regulatory T Cells Effectively Treats Acute Graft Versus Host Disease Preserving Graft Versus Tumor Effect (2013) (0)
- New Strategies for Fungal Infections after Hematopoietic Cell Transplantation : Prevention or Preemption ? (2007) (0)
- Bioluminescent tracking of candidate leukemic stem cell engraftment in immunocompromised mice (2005) (0)
- (CSF) and granulocyte-monocyte CSF between recombinant human granulocyte colony-stimulating factor hematopoiesis in the myelodysplastic syndromes: comparison Impact of marrow cytogenetics and morphology on in vitro (2011) (0)
- A Signal Hierarchy Model of Alloreactive T Cell Trafficking for the Organ Manifestation in Acute Graft-Versus-Host Disease. (2006) (0)
- Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation (2013) (0)
- Long-Term Outcomes of Patients with Peripheral T-Cell Lymphoma after Autologous Hematopoietic Cell Transplantation (2020) (0)
- Revealing kinetics of cytokine induced killer cell trafficking and survival in vivo (2006) (0)
- Erratum: Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation (Transplantation (July 15, 2005) 80, (134-139)) (2005) (0)
- T-cell dose peripheral blood hematopoietic cell transplantation is affected by CD8+ Engraftment and survival following reduced-intensity allogeneic (2013) (0)
- CD8+ T cells Role of NKG2D signaling in the cytotoxicity of activated and expanded (2010) (0)
- ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD (2022) (0)
- Adoptive Transfer of NKT Cells Reduces GVHD Severity Via an IFN-γ And IL-4 Dependent Mechanism (2009) (0)
- Single-cell Transcriptomics Reveal Different Maturation Stages and Sublineages Commitment of Human Thymic Invariant Natural Killer T cells (2022) (0)
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4 (cid:1) CD25 (cid:1) Foxp3 (cid:1) regulatory T cells (2011) (0)
- Interference with Inflammation Induced Endothelial Receptors Prevents Acute Graft-Versus-Host Disease. (2009) (0)
- Predictive Markers for Acute Graft-Versus-Host Disease in the Peripheral Blood - Surface Receptor Profile Defines Alloreactive T Cells In Vivo . (2006) (0)
- Cytokines for the Treatment of Myelodysplastic Syndromes and Other Bone Marrow Failure States (1999) (0)
- Immune Characterization of Ibrutinib Therapy Following Allohct That Provides GVL Benefit without Gvhd (2016) (0)
- Membranous Glomerulonephritis and Nephrotic Syndrome as a Late Manifestation of Chronic Graft-Versus-Host Reaction Following Allogeneic Transplantation for Hematologic Malignancy. (2006) (0)
- Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience (2014) (0)
- Definition of a Diagnostic Window Prior to the Onset of Clinically Apparent Acute Graft-Versus-Host Disease. (2010) (0)
- Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents. (2023) (0)
- 152: Long Term Remission in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Patients After Allogeneic Myeloablative Hematopoietic Cell Transplantation (HCT) Using Matched Related Donors: The 20 Year Experience at Stanford University and City of Hope National Medical Center (2008) (0)
- Mast Cells Suppress GVHD in a Mechanism Independent of CD4+CD25+ Regulatory T Cells (2011) (0)
- Allogeneic Hematopoietic Cell Nanoparticle-Labeled Dendritic Cells Tolerogenic Function of Inhibition on Lymphoid Homing and Impact of Mammalian Target of Rapamycin (2008) (0)
- Assessment of the near-Infrared Fluorescent Protein FP635 for Dynamic In Vivo Imaging in Models of Adaptive Immune Responses. (2009) (0)
- Prevention and Therapy of Relapse Following Autologous Hematopoietic Cell Transplantation (2007) (0)
- Assessment Of The Utility Of Subset Donor Chimerism For Predicting Event-Free Survival After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using TLI And ATG (2010) (0)
- TRANSPLANTATION CD 4 1 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD 4 1 CD 25 1 FoxP 3 1 regulatory T cells (2014) (0)
- The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models (2016) (0)
- Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Significant Increase in Survival in the Post-Targeted Immunotherapy Era (2020) (0)
- 47: CD4+CD25+ regulatory T cells enhance immune reconstitution following allogeneic hematopoietic cell transplantation by protecting thymic and lymphoid compartments from graft-versus-host disease damage without impacting T cell repertoire development (2007) (0)
- Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects (2022) (0)
- 8Trafficking of ex vivo expanded donor derived dendritic cells after allogeneic BMT (2003) (0)
- Role of NKG2D in the induction of mouse natural killer cell exhaustion (IRC8P.473) (2014) (0)
- The role of peyer’s patches and mesenteric lymph nodes in acute GVHD: a study guided by bioluminescence imaging in vivo (2004) (0)
- TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN (2013) (0)
- Analysis of Expanded Human Cytokine Induced Killer Cells for Cellular Therapy. (2005) (0)
- A Proinflammatory Invariant Natural Killer T Cells Phenotypic State Associates with Human Graft-Versus-Host Disease Onset and Response (2018) (0)
- A Proinflammatory Invariant Natural Killer T Cell Phenotypic State Associates with Human Graft-Versus-Host Disease Onset (2019) (0)
- Agonistic Anti-DR3 Antibody Expands Treg and Reduces Experimental Acute Graft-Versus-Host Disease (2013) (0)
- cell transplantation for aggressive non-Hodgkin's lymphoma Rituximab as adjuvant to high-dose therapy and autologous hematopoietic (2013) (0)
- Anen, tissue and cells against damage caused by the immune system (1999) (0)
- Expanded CD4+Foxp3+ Regulatory T Cells through DR3 Signaling Have a Distinct Immunophenotype and Abrogate the Lethal Acute-Graft and Host Disease after Allogeneic Transplantation (2015) (0)
- Early treatment with CD4+CD25+ regulatory T cells provides prolonged suppressive effects which control evolving but not established graft-versus-host-disease (2006) (0)
- (F2) Granulocyte colony-stimulating factor (G-CSF) in the treatment of myelodysplastic syndromes (MDS) (1991) (0)
- Cellular immunotherapy redirected by bispecific antibodies in primary ovarian cancer cells: A preclinical study. (2006) (0)
- In vivo kinetics of acute graft-versus-host disease in conditioned vs. unconditioned hosts (2006) (0)
- Activation of DR3 Signaling Expands Recipient Derived Regulatory T Cells and Enhances Donor Immune Reconstitution Derived from Allogeneic Hematopoietic Stem Cells (2014) (0)
- Survival Following Post-HCT Relapse in Adult Acute Lymphoblastic Leukemia Has Improved in the Era of Novel Immunotherapies: A Single Institution Analysis (2020) (0)
- erythropoietin: evidence for in vivo synergy with recombinant human granulocyte colony-stimulating factor and Maintenance treatment of the anemia of myelodysplastic syndromes (2011) (0)
- Isolation and Characterization of Human CD4+CD25+ T Regulatory Cells for Early Phase Clinical Trials in Hematopoietic Cell Transplantation. (2005) (0)
- Adoptively Transferred NK Cells Home to Tumor Sites and Accumulate With Tumor Growth But Do Not Lead to Tumor Regression in a Murine B-Cell Lymphoma Model (2011) (0)
- Tissue-Specific Homing of Natural Killer Cells in Allogeneic Bone Marrow Transplantation. (2006) (0)
- Differential Impact of Host Derived Interleukin-18 on Regulatory and Conventional T Cell Expansion Following Murine Allogeneic Hematopoietic Cell Transplantation. (2007) (0)
- Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma (2020) (0)
- Early Results of a Phase I Study of CAR-T Cells + NKTR-255 (PEG-IL-15) in Adults with R/R ALL (2023) (0)
- CD4+ Invariant Natural Killer T Cells Require NKG2D To Protect From Lethal Acute Graft-Versus-Host Disease (2013) (0)
- Chronic stimulation results in NK cell function impairment mediated by NKG2D (2017) (0)
- Silica-Induced Impairment of Macrophage Function Reduces GVHD Severity and Improves Survival (2011) (0)
- Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells (2015) (0)
- Orca-T Results in High Gvhd-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies: Results of a Single Center Phase 2 and a Multicenter Phase 1b Study (2021) (0)
- Human CIK Maintain Their In Vitro and In Vivo Anti-Tumor Ability after Cryopreservation. (2005) (0)
- Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity (2008) (0)
- Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms. (2012) (0)
- Allogeneic Cytokine-Induced Killer Cells Traffick to GVHD Target Tissue but Cause Less GVHD, While Retaining Tumor Cytotoxicity and Facilitating Bone Marrow Engraftment. (2006) (0)
- Outcomes for Myelofibrosis Patients Following Myeloablative Allogeneic Stem Cell Transplantation Using the Orca-T Graft from HLA-Matched Related and Unrelated Donors (2021) (0)
- Validation of the hematopoietic cell transplantation-specific comorbidity index in non-myeloablative allogeneic stem cell transplantation. (2016) (0)
- Cell Stem Cell Tolerance to ESCs and iPSCs by Costimulatory Blockade well as the trafficking and costimulation of T cells (2011) (0)
- Treatment of Donors with Death Receptor 3 Agonistic Fusion Protein TL1A-Ig (with and Without Low Dose IL-2) Leads to Regulatory T Cell Expansion and Activation with Reduction in Graft-Versus-Host Disease (2018) (0)
- Regulatory T Cell Therapy for Immunomodulation After Allogeneic Hematopoietic Cell Transplantation (2010) (0)
- 301: Selective expansion of human regulatory (CD4+CD25+CD127LowFOXP3+) cells to high purity by inhibiting expansion of CD4+CD25+CD127HighFOXP3- conventional T cells with rapamycin (2007) (0)
- Engineering Human Invariant Natural Killer T (iNKT) Cells to Overexpress Immunomodulatory Cytokines (2021) (0)
- Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells (2017) (0)
- Similarities In the Initial Events of Murine Gvhd Across Minor. as Compared to Major, Histocompatibility Barriers. (2010) (0)
- chronic myeloid leukemia The effects of imatinib mesylate treatment before allogeneic transplant for (2012) (0)
- Development of a Minimal Residual Disease Model for Ovarian Cancer Using Bioluminescence in an Immunocompetent Mouse Model (2007) (0)
- Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells (2010) (0)
- 756. The Use of Immune Cell Trafficking to Deliver an Oncolytic Virus to Tumors (2005) (0)
- 21: Preparation of Highly Purified Regulatory T Cells for Clinical Applications (2008) (0)
- In vivo spatial and temporal analyses in mice reveal redundancy of lymphoid tissues in inducing acute GVHD after allogeneic hematopoietic cell transplantation (2005) (0)
- In vivo trafficking of CD4+CD25+ regulatory T-cells in allogeneic recipients using bioluminescence imaging (2005) (0)
- Isolation and characterization of human CD4+CD25+ T regulatory cells for early phase clinical trials in hematopoietic cell transplantation (2006) (0)
- 100 Already? (2021) (0)
- Phase I/II Trial of a Novel Gemcitabine and Vinorelbine-Containing Conditioning Regimen in Autologous Hemotopoietic Cell Transplantation for High-Risk Recurrent and Refractory Hodgkin Lymphoma. (2008) (0)
- New Pre-Transplant Regimens (2020) (0)
- Development of a minimal residual disease ovarian cancer model in immunocompetent mice (2008) (0)
- Allogeneic Effector Cell Populations (2003) (0)
- Outcomes for Acute Myeloid Leukemia Relapse after Allogeneic Hematopoietic Cell Transplantation Remain Poor in the Modern Era (2022) (0)
- A Novel Model of Pre-Emptive ECP Treatment Shows Significant Reduction of Gvhd-Related Mortality In Mice, (2011) (0)
- Tracking T Cell Activation By OX40 Immuno-PET: A Novel Strategy for Imaging of Graft Versus Host Disease (2018) (0)
- High Dose Therapy and Autologous Hematopoietic Cell Transplantation for Primary Refractory Diffuse Large Cell Non-Hodgkin’s Lymphoma. (2006) (0)
- Functional analysis of tumor cell growth and clearance in living animals (1999) (0)
- Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors (2016) (0)
- Orca-T, a Precision Treg-Engineered Donor Product, in Myeloablative HLA-Matched Transplantation Prevents Acute Gvhd with Less Immunosuppression in an Early Multicenter Experience (2021) (0)
- Enhanced Immune Reconstitution and Function by CD4+CD25+ Regulatory T Cells Following Allogeneic Hematopoietic Cell Transplantation. (2005) (0)
- TRANSPLANTATION Third-party CD 4 1 invariant natural killer T cells protect from murine GVHD lethality (2015) (0)
- Memory Phenotype CD8+T Cells Are Superior to Naive CD8+T Cells in Separating Graft Anti-Tumor Activity From Gvhd After Bone Marrow Transplantation; Application to DLI. (2009) (0)
- in minimal GVHD with retention of antitumor activity In vivo trafficking and survival of cytokine-induced killer cells resulting (2013) (0)
- Immunobiology of Transplantation (2008) (0)
- The Development of Carhlh after Axicabtagene Ciloleucel Is Associated with Poor Outcomes (2022) (0)
- Karl G. Blume, MD (1937-2013) (2013) (0)
- Concordance of Next Generation Sequencing-Based Measurable Residual Disease between Peripheral Blood and Bone Marrow in Adults with Acute Lymphoblastic Leukemia Receiving Cellular Therapies (2021) (0)
- The Double Benefit of ex-vivo Generated Anti 3rd Party CD8 T Cells With Central Memory Phenotype: Enhanced BM Engraftment Coupled With Marked GVL in the Absence of GVHD (2011) (0)
- CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts (2015) (0)
- iNKT Cell Stimulation with Liposomal Alpha/Gal/Cer Amplifies Proliferation of Adoptively Transferred Regulatory T Cells In Vivo and Reduces GvHD (2018) (0)
- In Vivo Monitoring of Immunotherapies for Cancer in Intact Mice• 802 (1998) (0)
- Gvhd Severity Is Regulated by the Adoptive Transfer Low Numbers of NKT Cells by a Mechanism Distinct From CD4+CD25+ Regulatory T Cells. (2009) (0)
- Immune Phenotypic Quantification of Axicabtagene Ciloleucel and Brexucabtagene Autoleucel Demonstrates Lymphoma Histology Specific Differences in CAR19 Expansion and Toxicity (2023) (0)
- A Functional Assay for Peripheral Blood T Cells to Predict Acute Graft-Versus-Host Disease. (2009) (0)
- CD4+FoxP3+ Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts (2014) (0)
- Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation (2016) (0)
- Ex-Vivo Expanded And Freshly Isolated CD4+CD25+FOXP3+ Regulatory T Cells Suppress Murine Acute GVHD With Different Potency (2010) (0)
- combination with erythropoietin (see comments) recombinant human granulocyte colony-stimulating factor in Treatment of the anemia of myelodysplastic syndromes using (2011) (0)
- Left running head: HORWITZ et al. Right running head: RITUXIMAB AND AUTOTRANSPLANTATION FOR NHL Journal section: CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Rituximab as adjuvant to high dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin’s lymp (2003) (0)
- LYMPHOID NEOPLASIA MLL leukemia induction by genome editing of human CD34 1 hematopoietic cells (2015) (0)
- A preclinical study of cellular immunotherapy redirected by bispecific antibodies in uterine cell lines and primary cancer cells. (2006) (0)
- The Graying of Clinical Transplantation (2006) (0)
- Autologous stem cell transplantation versus no transplant in patients above 70 with multiple myeloma. (2020) (0)
- From blood to brain: Contribution of endogenous bone marrow-deriverd mesenchymal stem cells to the brain repair after stroke (2013) (0)
- Repertoire of Murine T Cells in Target Tissues of MHC-Matched and -Mismatched Graft-Versus-Host Disease (2017) (0)
- Orca-T Demonstrates Encouraging Overall Survival, Gvhd Reduction, and Tolerability in Patients with Hematologic Malignancies (2022) (0)
- hematopoietic cell transplantation Reconstitution of NK cell receptor repertoire followingHLA-matched (2013) (0)
- IL‐2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor (2022) (0)
- Autoimmune Diseases : When Homeland Security Fails (2004) (0)
- Long-Term Outcomes of AML Patients Using Total Lymphoid Irradiation with Anti-Thymocyte Globulin (2016) (0)
- Regulatory T Cell Immunotherapy in Immune-Mediated Diseases (2015) (0)
- Silensilencing Human NKG2D, DAP10 and DAP12 Reduces Cytotoxicity of in Vivo Activated CD8 + T and NK Cells. (2004) (0)
- Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. (2021) (0)
- Editorial from the new Editors (1997) (0)
- Long-Term Follow-Up of Metastatic Breast Cancer Patients Receiving Highly Purified Autologous CD34+Thy-1+ Hematopoietic Stem Cells After High-Dose Chemotherapy (2011) (0)
- Prevention of Acute Graft-Versus-Host Disease Using an Engineered Mouse Orthogonal IL-2/IL-2Rβ Regulatory T Cells (2021) (0)
- RNA and TCR Sequencing Shed Light on Mechanisms of Treg Suppression in a Murine Model of Acute GvHD (2020) (0)
- Cytotoxicity of human CD8+ T-cells and NK-cells is suppressed by an alternative NKG2D splice variant (90.19) (2009) (0)
- Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort (2018) (0)
- Tandem BMT meetings workshop descriptions (2004) (0)
- Primary Human Acute Myeloid Leukemia Stem Cells Show Reduced Sensitivity To Natural Killer Cell-Mediated Killing (2010) (0)
- The Inhibitory Receptor LAG-3 Is Not Essential for Regulatory T Cells Function but Influences Donor T Cell Potency in Acute Graft-Versus-Host-Disease (2011) (0)
- Allogeneic Effector Cell Populations Separating GVL from GVHD (2013) (0)
- Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells (2018) (0)
- Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease (2022) (0)
- 335: Inhibition of HMG-CoA reductase activity with statins provides acute-graft-versus-host disease protection by Th-2 cytokine induction while sparing graft-versus-leukemia activity (2007) (0)
- EX VIVO activated and expanded CD8+ T cells recognize malignant cells through a TCR independent and NKG2D dependent pathway (2004) (0)
- Tracking T Cell Activation By OX40 ImmunoPET: A Novel Strategy for Imaging of Graft Versus Host Disease (2019) (0)
- Activation of Regulatory T Cells with IL-2 and TNF-α to Promote Homing to the Gut and to Improve Acute GvHD Prevention (2019) (0)
- CD22 CAR T Cell Therapy Induces Durable Remissions in Patients with Large B Cell Lymphoma Who Relapse after CD19 CAR T Cell Therapy (2023) (0)
- Engraftment of Embryonic Stem Cells and Differentiated Progeny Following Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells (2015) (0)
- Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity (2014) (0)
- New Guidelines Help Health Professionals Recognize and Manage Late Complications (2006) (0)
- T Cell Activation In Vivo + CD8 and + Opsonized Antigen Leading to CD4 Plasmacytoid Dendritic Cells Take Up (2008) (0)
- Extracellular release of damaged mitochondria induced by cytotoxic conditioning exacerbates GVHD (2023) (0)
- Preface to the Fifth Edition (2005) (0)
- IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease Following Bone Marrow Transplantation, (2011) (0)
- Single Dose Administration of ECP Treated Cells Prior to Transplantation Significantly Increases Survival in a MHC-Mismatched Model of Acute GvHD (2011) (0)
- Kinetics of Murine GVHD Induction Across Minor and Major Histocompatibility Barriers (2011) (0)
- Survival and homing of ex vivo expanded donor derived dendritic cells after allogeneic BMT (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Roberts S. Negrin?
Roberts S. Negrin is affiliated with the following schools: